A theme focused on building and expanding collaborative research and development frameworks with domestic and overseas pharmaceutical companies, and turning research成果 from partners into development candidate compounds. It covers ongoing alliance activities with pharmaceutical companies broadly, rather than being limited to a specific disease, technology or single partnership.